Dr. Andrew Lipman, who practices at Florida Cancer Specialists (FCS) in Bonita Springs and Naples West offices, was a co-author of a research paper evaluating the safety and efficacy of combining three drug agents – bendamustine, bortezomib and rituximab (BBR) – in patients with previously untreated low-grade lymphoma. Published January 2018 in the British Journal of Haematology,Continue Reading

Behind a message of “Fight with Courage,” Tampa resident Valarie Schlosser will be one of the 25 people featured in a new PSA rotating in Times Square this March for Colorectal Cancer Awareness Month. Schlosser was diagnosed with colorectal cancer at 49 and has become an ambassador for the country’sContinue Reading

Radiation is a commonly used therapeutic option to treat liver metastases, with the majority of tumors maintained under control after one year. However, some patients do not respond as well to radiation treatment, and the factors that predict patient outcomes are unclear. Moffitt Cancer Center researchers report that liver metastases haveContinue Reading